Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment

Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment

Osteosarcoma survival rates have been largely unchanged for several decades, and treatment response is variable. Here, the authors analyzed genomic, transcriptomic and epigenomic data from 121 osteosarcoma patients and identify subtypes related to treatment outcome.

Bibliographic Details
Main Authors: Yafei Jiang, Jinzeng Wang, Mengxiong Sun, Dongqing Zuo, Hongsheng Wang, Jiakang Shen, Wenyan Jiang, Haoran Mu, Xiaojun Ma, Fei Yin, Jun Lin, Chongren Wang, Shuting Yu, Lu Jiang, Gang Lv, Feng Liu, Linghang Xue, Kai Tian, Gangyang Wang, Zifei Zhou, Yu Lv, Zhuoying Wang, Tao Zhang, Jing Xu, Liu Yang, Kewen Zhao, Wei Sun, Yujie Tang, Zhengdong Cai, Shengyue Wang, Yingqi Hua
Format: Article
Language:English
Published: Nature Portfolio 2022-11-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-34689-5

Internet

https://doi.org/10.1038/s41467-022-34689-5

Similar Items